
Jerry B. Dennison
Examiner (ID: 40, Phone: (571)272-3910 , Office: P/2443 )
| Most Active Art Unit | 2443 |
| Art Unit(s) | 2443, 2409, 2143, 2419 |
| Total Applications | 1015 |
| Issued Applications | 700 |
| Pending Applications | 74 |
| Abandoned Applications | 250 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17154943
[patent_doc_number] => 20210315994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => DELIVERY OF NEGATIVELY CHARGED PROTEINS USING CATIONIC LIPIDS
[patent_app_type] => utility
[patent_app_number] => 17/130812
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17130812
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/130812 | DELIVERY OF NEGATIVELY CHARGED PROTEINS USING CATIONIC LIPIDS | Dec 21, 2020 | Pending |
Array
(
[id] => 17141967
[patent_doc_number] => 20210309979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Enzyme Variants With Improved Ester Synthase Properties
[patent_app_type] => utility
[patent_app_number] => 17/116817
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116817
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116817 | Enzyme Variants With Improved Ester Synthase Properties | Dec 8, 2020 | Abandoned |
Array
(
[id] => 18837717
[patent_doc_number] => 11845780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Mutant lysenin pores
[patent_app_type] => utility
[patent_app_number] => 17/108536
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28332
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17108536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/108536 | Mutant lysenin pores | Nov 30, 2020 | Issued |
Array
(
[id] => 16686749
[patent_doc_number] => 20210069224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => Compositions and Methods for Topical and Diagnostic and Therapeutic Transport
[patent_app_type] => utility
[patent_app_number] => 17/100806
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/100806 | Compositions and Methods for Topical and Diagnostic and Therapeutic Transport | Nov 19, 2020 | Abandoned |
Array
(
[id] => 19622905
[patent_doc_number] => 12161697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Nanospheres for bone fracture
[patent_app_type] => utility
[patent_app_number] => 17/094114
[patent_app_country] => US
[patent_app_date] => 2020-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 22905
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094114
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/094114 | Nanospheres for bone fracture | Nov 9, 2020 | Issued |
Array
(
[id] => 18058372
[patent_doc_number] => 20220389458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => LOW VOLUME TRANSFECTION
[patent_app_type] => utility
[patent_app_number] => 17/771333
[patent_app_country] => US
[patent_app_date] => 2020-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/771333 | LOW VOLUME TRANSFECTION | Nov 1, 2020 | Abandoned |
Array
(
[id] => 17198690
[patent_doc_number] => 20210338784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => Botulinum Toxin Pharmaceutical Composition Comprising Tannic Acid
[patent_app_type] => utility
[patent_app_number] => 17/081853
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/081853 | Botulinum Toxin Pharmaceutical Composition Comprising Tannic Acid | Oct 26, 2020 | Abandoned |
Array
(
[id] => 17035013
[patent_doc_number] => 20210251971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
[patent_app_type] => utility
[patent_app_number] => 17/079859
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/079859 | Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases | Oct 25, 2020 | Pending |
Array
(
[id] => 17035013
[patent_doc_number] => 20210251971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
[patent_app_type] => utility
[patent_app_number] => 17/079859
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/079859 | Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases | Oct 25, 2020 | Pending |
Array
(
[id] => 16806230
[patent_doc_number] => 20210128783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => LAMINATED SKIN MIMETIC
[patent_app_type] => utility
[patent_app_number] => 17/061245
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/061245 | LAMINATED SKIN MIMETIC | Sep 30, 2020 | Abandoned |
Array
(
[id] => 17769383
[patent_doc_number] => 11401311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Recombinant activin A precursor protein
[patent_app_type] => utility
[patent_app_number] => 17/025242
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10722
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/025242 | Recombinant activin A precursor protein | Sep 17, 2020 | Issued |
Array
(
[id] => 17897375
[patent_doc_number] => 20220307037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => SYSTEMS AND METHODS FOR PROTEIN EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/761929
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761929
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761929 | SYSTEMS AND METHODS FOR PROTEIN EXPRESSION | Sep 14, 2020 | Pending |
Array
(
[id] => 16713322
[patent_doc_number] => 20210080469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => ANOLITER-SCALE SAMPLE PROCESSING AND MASS SPECTROMETRY ACQUISITION METHOD FOR SINGLE CELL PROTEOMICS
[patent_app_type] => utility
[patent_app_number] => 17/021319
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021319 | ANOLITER-SCALE SAMPLE PROCESSING AND MASS SPECTROMETRY ACQUISITION METHOD FOR SINGLE CELL PROTEOMICS | Sep 14, 2020 | Pending |
Array
(
[id] => 16776627
[patent_doc_number] => 20210113704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => NOVEL TOXIN-DERIVED DELIVERY CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 17/015011
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/015011 | Toxin-derived delivery constructs for pulmonary delivery | Sep 7, 2020 | Issued |
Array
(
[id] => 16776394
[patent_doc_number] => 20210113471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => ANNELID HAEMOGLOBIN LYOPHILISATION PROCESS
[patent_app_type] => utility
[patent_app_number] => 17/014445
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014445
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/014445 | Annelid haemoglobin lyophilisation process | Sep 7, 2020 | Issued |
Array
(
[id] => 16855221
[patent_doc_number] => 20210155966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => PRODUCTION OF STEVIOL GLYCOSIDES IN RECOMBINANT HOSTS
[patent_app_type] => utility
[patent_app_number] => 17/014311
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014311
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/014311 | PRODUCTION OF STEVIOL GLYCOSIDES IN RECOMBINANT HOSTS | Sep 7, 2020 | Abandoned |
Array
(
[id] => 16932444
[patent_doc_number] => 20210198333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE
[patent_app_type] => utility
[patent_app_number] => 16/997197
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997197
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997197 | EphA2 T-cell epitope agonists and uses therefore | Aug 18, 2020 | Issued |
Array
(
[id] => 18209482
[patent_doc_number] => 20230055742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => Strain of Beijerinckia Fluminensis and Application Thereof in Arsenic Oxidation
[patent_app_type] => utility
[patent_app_number] => 17/790406
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790406
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790406 | Strain of Beijerinckia Fluminensis and Application Thereof in Arsenic Oxidation | Aug 9, 2020 | Abandoned |
Array
(
[id] => 16437405
[patent_doc_number] => 20200354731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => ENDOPLASMIC RETICULUM TARGETING SIGNAL
[patent_app_type] => utility
[patent_app_number] => 16/940440
[patent_app_country] => US
[patent_app_date] => 2020-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940440
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/940440 | ENDOPLASMIC RETICULUM TARGETING SIGNAL | Jul 27, 2020 | Abandoned |
Array
(
[id] => 16435801
[patent_doc_number] => 20200353126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => Sterilization Process
[patent_app_type] => utility
[patent_app_number] => 16/940431
[patent_app_country] => US
[patent_app_date] => 2020-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940431
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/940431 | Sterilization process | Jul 27, 2020 | Issued |